About Us

Archives






PMV Pharmaceuticals Reports Second Quarter 2021 Financial Results and Corporate Highlights

Posted: August 15, 2021 at 1:51 am


CRANBURY, N.J., Aug. 13, 2021 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a clinical-stage oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies designed to target p53 mutants, today reported financial results for the second quarter ended June 30, 2021 and provided corporate highlights.

Read more:
PMV Pharmaceuticals Reports Second Quarter 2021 Financial Results and Corporate Highlights

Related Post

No Comments

No comments yet.

Sorry, the comment form is closed at this time.